Literature DB >> 2241167

Human immunodeficiency viral protease is catalytically active as a fusion protein: characterization of the fusion and native enzymes produced in Escherichia coli.

J Boutelje1, A R Karlström, M G Hartmanis, E Holmgren, A Sjögren, R L Levine.   

Abstract

Processing of the gag and pol gene precursor proteins of retroviruses is essential for the production of mature infectious virions. The processing is directed by a viral protease that itself is part of these precursors and is presumed to cleave itself autocatalytically. To facilitate study of this process, the protease was produced as a fusion protein in Escherichia coli. In this construct, the 10,793-Da protease was preceeded by two copies of a modified IgG binding domain derived from protein A. The IgG binding domain was linked to the protease by an Asp-Pro peptide bond which could not be cleaved by the viral protease. A dimer of the 25,400-Da fusion protein was catalytically active, specifically cleaving a substrate peptide at the correct Tyr-Pro bond. Thus, the fusion protein could serve as a model of the viral gag-pol polyprotein. The finding that the fusion protein was catalytically active supports the suggestion that a gag-pol dimer can initiate a proteolytic cascade after budding of the immature virus. The fusion protein also provided a source of authentic protease. The protease was released from the fusion construct by incubation with formic acid, cleaving the Asp-Pro linkage which had been inserted between the IgG binding domain and the protease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2241167     DOI: 10.1016/0003-9861(90)90624-8

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  4 in total

1.  Functional characterization of roles of GalR and GalS as regulators of the gal regulon.

Authors:  M Geanacopoulos; S Adhya
Journal:  J Bacteriol       Date:  1997-01       Impact factor: 3.490

2.  HIV-I protease. Cloning, expression, and purification.

Authors:  N I Dergousova; A M Volynskaya; L D Rumsh
Journal:  Appl Biochem Biotechnol       Date:  1996 Oct-Nov       Impact factor: 2.926

3.  Copper inhibits the protease from human immunodeficiency virus 1 by both cysteine-dependent and cysteine-independent mechanisms.

Authors:  A R Karlström; R L Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

4.  Thrombin and H64A subtilisin cleavage of fusion proteins for preparation of human recombinant parathyroid hormone.

Authors:  G Forsberg; M Brobjer; E Holmgren; K Bergdahl; P Persson; K M Gautvik; M Hartmanis
Journal:  J Protein Chem       Date:  1991-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.